185 related articles for article (PubMed ID: 23279641)
1. Brain metastases from prostate cancer: an 11-year analysis in the MRI era with emphasis on imaging characteristics, incidence, and prognosis.
Hatzoglou V; Patel GV; Morris MJ; Curtis K; Zhang Z; Shi W; Huse J; Rosenblum M; Holodny AI; Young RJ
J Neuroimaging; 2014; 24(2):161-6. PubMed ID: 23279641
[TBL] [Abstract][Full Text] [Related]
2. Prostate Cancer Brain Metastases: A Single-Institution Experience.
Bhambhvani HP; Greenberg DR; Srinivas S; Hayden Gephart M
World Neurosurg; 2020 Jun; 138():e445-e449. PubMed ID: 32147556
[TBL] [Abstract][Full Text] [Related]
3. Brain metastasis from prostate carcinoma: The M. D. Anderson Cancer Center experience.
Tremont-Lukats IW; Bobustuc G; Lagos GK; Lolas K; Kyritsis AP; Puduvalli VK
Cancer; 2003 Jul; 98(2):363-8. PubMed ID: 12872358
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. The prognosis of different distant metastases pattern in prostate cancer: A population based retrospective study.
Shou J; Zhang Q; Wang S; Zhang D
Prostate; 2018 May; 78(7):491-497. PubMed ID: 29436722
[TBL] [Abstract][Full Text] [Related]
6. Is there a favorable subset of patients with prostate cancer who develop oligometastases?
Singh D; Yi WS; Brasacchio RA; Muhs AG; Smudzin T; Williams JP; Messing E; Okunieff P
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):3-10. PubMed ID: 14697414
[TBL] [Abstract][Full Text] [Related]
7. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer.
Birkhäuser FD; Studer UE; Froehlich JM; Triantafyllou M; Bains LJ; Petralia G; Vermathen P; Fleischmann A; Thoeny HC
Eur Urol; 2013 Dec; 64(6):953-60. PubMed ID: 23916692
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Brain Metastases on Follow-up
Nia ES; Garland LL; Eshghi N; Nia BB; Avery RJ; Kuo PH
J Nucl Med Technol; 2017 Sep; 45(3):193-197. PubMed ID: 28705927
[TBL] [Abstract][Full Text] [Related]
9.
Selnæs KM; Krüger-Stokke B; Elschot M; Willoch F; Størkersen Ø; Sandsmark E; Moestue SA; Tessem MB; Halvorsen D; Kjøbli E; Angelsen A; Langørgen S; Bertilsson H; Bathen TF
Eur Radiol; 2018 Aug; 28(8):3151-3159. PubMed ID: 29294158
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Sites of Visceral Metastatic Disease in Prostate Cancer: A Population-based Study of 12,180 Patients.
Budnik J; Suri J; Bates JE; Bylund KC; Milano MT
Clin Genitourin Cancer; 2019 Aug; 17(4):260-267. PubMed ID: 31101579
[TBL] [Abstract][Full Text] [Related]
11. Discovery of additional brain metastases on the day of stereotactic radiosurgery: risk factors and outcomes.
Garcia MA; Lazar A; Duriseti S; Raleigh DR; Hess CP; Fogh SE; Barani IJ; Nakamura JL; Larson DA; Theodosopoulos P; McDermott M; Sneed PK; Braunstein S
J Neurosurg; 2017 Jun; 126(6):1756-1763. PubMed ID: 27367235
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiosurgical treatment of parenchymal brain metastases from prostate adenocarcinoma.
Kim SH; Chao ST; Toms SA; Vogelbaum MA; Barnett GH; Suh JH; Weil RJ
Surg Neurol; 2008 Jun; 69(6):641-6; discussion 646. PubMed ID: 18262258
[TBL] [Abstract][Full Text] [Related]
13. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Conventional Magnetic Resonance Imaging for Adult Patients with Brain Tumors.
Klingelhöfer L; Mucha D; Geiger K; Koch R; von Kummer R
Clin Neuroradiol; 2015 Sep; 25(3):281-9. PubMed ID: 24828225
[TBL] [Abstract][Full Text] [Related]
15. Modelling Study with an Interactive Model Assessing the Cost-effectiveness of
Scholte M; Barentsz JO; Sedelaar JPM; Gotthardt M; Grutters JPC; Rovers MM
Eur Urol Focus; 2020 Sep; 6(5):967-974. PubMed ID: 30826284
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer.
Eschmann SM; Pfannenberg AC; Rieger A; Aschoff P; Müller M; Paulsen F; Anastasiadis A; Claussen CD; Bares R; Schlemmer HP
Nuklearmedizin; 2007; 46(5):161-8; quiz N47-8. PubMed ID: 17938748
[TBL] [Abstract][Full Text] [Related]
17. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?
Lecouvet FE; El Mouedden J; Collette L; Coche E; Danse E; Jamar F; Machiels JP; Vande Berg B; Omoumi P; Tombal B
Eur Urol; 2012 Jul; 62(1):68-75. PubMed ID: 22366187
[TBL] [Abstract][Full Text] [Related]
18. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients.
Thoeny HC; Triantafyllou M; Birkhaeuser FD; Froehlich JM; Tshering DW; Binser T; Fleischmann A; Vermathen P; Studer UE
Eur Urol; 2009 Apr; 55(4):761-9. PubMed ID: 19144456
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of patients with prostate carcinoma presenting as nonregional lymph node metastases.
Furuya Y; Akakura K; Akimoto S; Ito H
Urol Int; 1998 Oct; 61(1):17-21. PubMed ID: 9792977
[TBL] [Abstract][Full Text] [Related]
20. [Silent brain metastasis in the initial staging of lung cancer: evaluation by computed tomography and magnetic resonance imaging].
de Cos Escuín JS; Menna DM; González MA; Quirantes JZ; Vicente CD; Calvo MC
Arch Bronconeumol; 2007 Jul; 43(7):386-91. PubMed ID: 17663891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]